Famotidine and Auryxia drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Famotidine (famotidine) and Auryxia (ferric citrate). Common drug interactions include chronic kidney disease among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Famotidine and Auryxia. It is created by eHealthMe based on reports of 36 people who take the same drugs from the FDA, and is updated regularly.

What is Famotidine?

Famotidine has active ingredients of famotidine. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 83,421 Famotidine users. Check the latest studies of Famotidine.

What is Auryxia?

Auryxia has active ingredients of ferric citrate. eHealthMe is studying from 2,253 Auryxia users. Check the latest studies of Auryxia.



On Jul, 21, 2026

36 people who take Famotidine and Auryxia together, and have interactions are studied.

Famotidine and Auryxia drug interactions.

What are the common drug interactions of Famotidine and Auryxia, by gender? *:

female:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Emotional distress
  4. Pain
  5. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  6. Anxiety
  7. Decreased activity
  8. Fluid overload (too much fluid in the blood)
  9. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  10. Nephrogenic anaemia (anaemia due to kidney disease)

male:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Nephrogenic anaemia (anaemia due to kidney disease)
  4. Renal injury (kidney injury)
  5. Renal tubular disorder (disease of kidney tubules)
  6. Tooth loss
  7. Abscess (pus)
  8. Urticaria (rash of round, red welts on the skin that itch intensely)
  9. Death
  10. Osteoarthritis (a joint disease caused by cartilage loss in a joint)

What are the common drug interactions of Famotidine and Auryxia, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Chronic kidney disease
  2. Emotional distress
  3. Pain
  4. Nephropathy (damage to or disease of a kidney)
  5. Renal failure (kidney dysfunction)
  6. Renal impairment (severely reduced kidney function)
  7. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)

40-49:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  4. Nephrogenic anaemia (anaemia due to kidney disease)
  5. Renal injury (kidney injury)
  6. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  7. Anxiety
  8. Decreased activity
  9. Emotional distress
  10. Fluid overload (too much fluid in the blood)

50-59:

  1. Chronic kidney disease
  2. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  3. Anxiety
  4. Blood glucose increased
  5. Blood potassium increased
  6. Depression
  7. Emotional distress
  8. Pain
  9. Renal tubular disorder (disease of kidney tubules)
  10. Tooth loss

60+:

  1. Chronic kidney disease
  2. Death
  3. Hypotension (abnormally low blood pressure)
  4. Malignant melanoma (skin cancer rises from melancytes)
  5. Nephrogenic anaemia (anaemia due to kidney disease)
  6. Renal impairment (severely reduced kidney function)
  7. Renal injury (kidney injury)
  8. Umbilical hernia (an outward bulging (protrusion) of the abdominal lining or part of the abdominal organ(s) through the area around the belly button)
  9. Renal failure (kidney dysfunction)
  10. Dysgeusia (disorder of the sense of taste)

What are the existing conditions these people have? *

  1. Pain: 10 people, 27.78%
  2. High Blood Cholesterol: 10 people, 27.78%
  3. Hiv Infection: 8 people, 22.22%
  4. Stress And Anxiety: 7 people, 19.44%
  5. Indigestion: 7 people, 19.44%
  6. Depression: 6 people, 16.67%
  7. High Blood Pressure: 6 people, 16.67%
  8. Anaemia (lack of blood): 5 people, 13.89%
  9. Renal Disorder (kidney disease): 5 people, 13.89%
  10. Nausea (feeling of having an urge to vomit): 5 people, 13.89%

* Approximation only. Some reports may have incomplete information.

Do you take Famotidine and Auryxia?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Famotidine and Auryxia:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Famotidine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Auryxia:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Famotidine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Auryxia and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on famotidine and ferric citrate (the active ingredients of Famotidine and Auryxia, respectively), and Famotidine and Auryxia (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: